SS, C., EJ, S., YG, K., & KM, K. (2026). Ischemic stroke neuroprotection revisited: Translational barriers and a phase-resolved, biomarker-anchored framework. Archives of pharmacal research, 49(1), 30. https://doi.org/10.1007/s12272-026-01593-1
Chicago Style (17th ed.) CitationSS, Cho, Shin EJ, Kim YG, and Kim KM. "Ischemic Stroke Neuroprotection Revisited: Translational Barriers and a Phase-resolved, Biomarker-anchored Framework." Archives of Pharmacal Research 49, no. 1 (2026): 30. https://doi.org/10.1007/s12272-026-01593-1.
MLA (9th ed.) CitationSS, Cho, et al. "Ischemic Stroke Neuroprotection Revisited: Translational Barriers and a Phase-resolved, Biomarker-anchored Framework." Archives of Pharmacal Research, vol. 49, no. 1, 2026, p. 30, https://doi.org/10.1007/s12272-026-01593-1.